380 related articles for article (PubMed ID: 7543171)
1. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
Kojda G; Stein D; Kottenberg E; Schnaith EM; Noack E
J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
[TBL] [Abstract][Full Text] [Related]
2. Effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate in experimental atherosclerosis.
Kojda G; Noack E
Agents Actions Suppl; 1995; 45():201-6. PubMed ID: 7717181
[TBL] [Abstract][Full Text] [Related]
3. The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis.
Hacker A; Müller S; Meyer W; Kojda G
Br J Pharmacol; 2001 Apr; 132(8):1707-14. PubMed ID: 11309242
[TBL] [Abstract][Full Text] [Related]
4. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion.
Dragoni S; Gori T; Lisi M; Di Stolfo G; Pautz A; Kleinert H; Parker JD
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1955-9. PubMed ID: 17641250
[TBL] [Abstract][Full Text] [Related]
5. Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.
Schuhmacher S; Oelze M; Bollmann F; Kleinert H; Otto C; Heeren T; Steven S; Hausding M; Knorr M; Pautz A; Reifenberg K; Schulz E; Gori T; Wenzel P; Münzel T; Daiber A
Diabetes; 2011 Oct; 60(10):2608-16. PubMed ID: 21844097
[TBL] [Abstract][Full Text] [Related]
6. Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance.
Müller S; Laber U; Müllenheim J; Meyer W; Kojda G
J Am Coll Cardiol; 2003 Jun; 41(11):1994-2000. PubMed ID: 12798571
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase.
Oppermann M; Dao VT; Suvorava T; Bas M; Kojda G
Br J Pharmacol; 2008 Oct; 155(3):335-42. PubMed ID: 18587420
[TBL] [Abstract][Full Text] [Related]
8. [Therapy with NO donors-antiatherogenic and antioxidant actions].
Grosser N; Schröder H
Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate.
Müller S; König I; Meyer W; Kojda G
J Am Coll Cardiol; 2004 Aug; 44(3):624-31. PubMed ID: 15358031
[TBL] [Abstract][Full Text] [Related]
10. Impairment of endothelium-dependent vasorelaxation in experimental atherosclerosis is dependent on gender.
Kojda G; Hüsgen B; Hacker A; Perings D; Schnaith EM; Kottenberg E; Noack E
Cardiovasc Res; 1998 Mar; 37(3):738-47. PubMed ID: 9659458
[TBL] [Abstract][Full Text] [Related]
11. Antiatherosclerotic effects of oral naftidrofuryl in cholesterol-fed rabbits involve inhibition of neutrophil function.
Kienbaum P; Braun M; Hohlfeld T; Weber AA; Sarbia M; Schrör K
J Cardiovasc Pharmacol; 1995 May; 25(5):774-81. PubMed ID: 7543172
[TBL] [Abstract][Full Text] [Related]
12. The effect of high-dose pentaerythritol tetranitrate on the development of nitrate tolerance in rabbits.
Müllenheim J; Müller S; Laber U; Thämer V; Meyer W; Bassenge E; Fink B; Kojda G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):269-75. PubMed ID: 11521170
[TBL] [Abstract][Full Text] [Related]
13. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
[TBL] [Abstract][Full Text] [Related]
14. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production.
Kojda G; Hacker A; Noack E
Eur J Pharmacol; 1998 Aug; 355(1):23-31. PubMed ID: 9754935
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of pentaerythrityl tetranitrate and its metabolites in human plasma by gas chromatography/mass spectrometry.
Stalleicken D; Kuntze U; Schmid B; Hiebl R; Ring J; Michaelis K
Arzneimittelforschung; 1997 Apr; 47(4):347-52. PubMed ID: 9150853
[TBL] [Abstract][Full Text] [Related]
17. Anti-atherosclerotic effect of beta-blocker with nitric oxide-releasing action on the severe atherosclerosis.
Thakur NK; Hayashi T; Sumi D; Kano H; Matsui-Hirai H; Tsunekawa T; Iguchi A
J Cardiovasc Pharmacol; 2002 Feb; 39(2):298-309. PubMed ID: 11791016
[TBL] [Abstract][Full Text] [Related]
18. Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits.
Hernandez A; Barberi L; Ballerio R; Testini A; Ferioli R; Bolla M; Natali M; Folco G; Catapano AL
Atherosclerosis; 1998 Mar; 137(1):71-6. PubMed ID: 9568738
[TBL] [Abstract][Full Text] [Related]
19. Effect of 5-isosorbide mononitrate on isosorbide dinitrate-induced relaxation of rabbit aortic rings.
Bennett BM; Tam GS; Van Alstyne K; Brien JF; Nakatsu K; Marks GS
Can J Physiol Pharmacol; 1984 Sep; 62(9):1194-7. PubMed ID: 6498631
[TBL] [Abstract][Full Text] [Related]
20. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
